Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
4,363,780
-
Shares change
-
-1,089,524
-
Total reported value, excl. options
-
$46,347,234
-
Value change
-
-$15,868,651
-
Put/Call ratio
-
4.04%
-
Number of buys
-
23
-
Number of sells
-
-41
-
Price
-
$10.62
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q1 2020
69 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q1 2020.
XBiotech Inc. - Common Shares, no par value (XBIT) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,363,780 shares
of 33,289,095 outstanding shares and own 13.11% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,290,904 shares), VANGUARD GROUP INC (719,169 shares), BANK OF AMERICA CORP /DE/ (276,763 shares), GEODE CAPITAL MANAGEMENT, LLC (276,658 shares), STATE STREET CORP (266,469 shares), NORTHERN TRUST CORP (171,008 shares), JANE STREET GROUP, LLC (142,001 shares), GOLDMAN SACHS GROUP INC (123,371 shares), Russell Investments Group, Ltd. (103,843 shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (100,071 shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.